Terms: = Brain cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28
4 results:
1. Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma.
Jo SY; Hong N; Lee S; Jeong JJ; Won J; Park J; Kim GJ; Kim SK; Kim S; Rhee Y
Exp Mol Med; 2023 May; 55(5):886-897. PubMed ID: 37121965
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract] [Full Text] [Related]
3. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract] [Full Text] [Related]
4. The surgical strategy and the molecular analysis of patients with parathyroid cancer.
Enomoto K; Uchino S; Ito A; Watanabe S; Shibuya H; Enomoto Y; Noguchi S
World J Surg; 2010 Nov; 34(11):2604-10. PubMed ID: 20480190
[TBL] [Abstract] [Full Text] [Related]